• / Free eNewsletters & Magazine
  • / My Account
Home>SIRFLOX Study Presented at ASCO 2015 Annual Meeting

SIRFLOX Study Presented at ASCO 2015 Annual Meeting

3party Content

Sat, 30 May 2015

CHICAGO, May 30, 2015 /PRNewswire/ --Clinical investigators cite significance of 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable metastatic colorectal cancer (mCRC) treated first line with SIR-Spheres® Y-90 resin microspheres plus chemotherapy The
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.